Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Datametrex AI Ltd V.DM

Alternate Symbol(s):  DTMXF

Datametrex AI Limited is a technology-focused company with exposure to artificial intelligence, healthcare, and mobile gaming. It is focused on collecting, analyzing and presenting structured and unstructured data using machine learning and artificial intelligence. The Company's products include AnalyticsGPT, Cyber Security, and Healthcare. AnalyticsGPT platform scans vast data streams from social media, news, blogs, forums, messengers, enterprise data, and the dark Web, creating predictive analytics. Cyber Security is a deep analytics platform that captures, structures, and visualizes vast amounts of unstructured social media data, which is used as a discovery tool that allows organizations to make decisions. It offers Nexa Products, which consists of NexaSecurity and NexaSMART. Healthcare consists of Imagine Health Centres, a multidisciplinary healthcare facility, and Medi-Call, a telehealth platform. The Company also offers a mobile blockchain game, Cereal Crunch.


TSXV:DM - Post by User

Comment by Resilience19on Feb 28, 2021 11:42am
261 Views
Post# 32681409

RE:Two is a very low P/E ratio.

RE:Two is a very low P/E ratio.@woldbird, good points.

On the issue of a P/E of 2, if I recall corretly, Marshall indicated this when the sp was around 0,17 and is, likely, based on projected 2020 earnings, meaning roughly $20M earning would be projected for 2020. This alone, if based on a more reasonable P/E of 10, would give a sp of 0.85 - still based on 2020 earnings.

As previously indicated by @Torlif, I think we can expect a concervatif earnings of $100M for 2021, based almost solely on C-19 testing (based on 12,000/wk tests). That alone would generate a sp of 4.25, if my math is correct. And we're not yet factoring in all the other irons in the fire.

Parallel to this, if DM shareholders were to receive Ronin shares, who's value is not factored into DM's sp, we're simply adding on the our value. So the more shares you add on before the Ronin announcement, likely the better.

Granted, people should avoid to put all their eggs in the same basket but at current DM sp valuation, the downside vs upside potential, between now and next year's annual results, is simply mind-boggling - unless I'm missing something and am totally out of the left field.



wildbird1 wrote: Is it a coincidence that immediately after the German interview (16 Feb 2021), there was very big volume traded and the SP jumped from 0.18$ to 0.38$, in just two trading days.

Could it be two very important things that M.Gunter mentioned in this interview.

1) First things mentioned..." Datametrex has a P/E of two"...(two is a very low P/E ratio).
The P/E ratio, or price-to-earnings ratio(stock price of a company divided by its earning per share) is a quick way to see if a stock is undervalued or overvalued, and generally speaking, the lower the P/E ratio is, the better it is for Datametrex and investors.

2) Second things mentioned " We are now closer to acheiving a "Positive EBITDA". Institutions and big investors love company with a positive EBITDA ( combined with a very low P/E ratio= bingo).

You shouldn't just zero in on the P/E ratio or the Positive EBITDA when you're deciding whether to buy shares. There are many other metrics to consider, like earnings charts, and sales figures.

Datametrex has record earnings and record sales quarters after quarters.

Datametrex has everything that institutions and big investors love(and much more), the big volume lately could indicate that some of them took an interest in Datametrex.

The future is looking great.









<< Previous
Bullboard Posts
Next >>